Background illustration for clinical trials search

Paid Clinical Trials Tacoma

Discover 1,438 paid clinical trials in Tacoma, Washington. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

for
Carcinoma, Non-Small-Cell Lung
Location: Olympia WA, Portland OR, Eugene OR, Spokane WA,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06667076

Phase2, Recruiting

A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

for
Non-small Cell Carcinoma, Non-Small Cell Lung Cancer Metastatic,
Location: Olympia WA, Portland OR, Gresham OR, Beaverton OR,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07144280

Phase3, Recruiting

A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).

for
Leukemia, Lymphocytic, Chronic, B-Cell,
Location: Olympia WA, Portland OR, Spokane WA, Reno NV,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT05947851

Phase3, Recruiting

A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)

for
Diffuse Large B-Cell Lymphoma
Location: Olympia WA, Portland OR, Reno NV, Edmonton,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06717347

Phase3, Recruiting

A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)

for
Non-Small Cell Lung Cancer (NSCLC)
Location: Olympia WA, Regina, Santa Barbara CA, Albuquerque NM,
Sponsor: Amgen

Sex: All

Age: 18 - 70+

Code: NCT05920356

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

for
Non-Small Cell Lung Cancer, Carcinoma, Non-Small-Cell Lung,
Location: Olympia WA, Abbotsford British Columbia,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT06758401

Phase3, Recruiting

AIMS Cancer Outcomes Study

for
Neoplasms, Neoplasm Malignant, Advanced Cancer,
Location: Seattle WA
Sponsor: Advanced Integrative Medical Science Institute

Sex: All

Age: 0+

Code: NCT04495790

Recruiting

Effectiveness of Aurix Therapy in Venous Leg Ulcers

for
Venous Leg Ulcers
Location: Bremerton WA, Meridian ID, Visalia CA, Arcadia CA,
Sponsor: Nuo Therapeutics

Sex: All

Age: 18+

Code: NCT02352454

Recruiting

Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery

for
Head and Neck Squamous Cell Carcinoma,
Location: Bremerton WA, Weston WI
Sponsor: ECOG-ACRIN Cancer Research Group

Sex: All

Age: 18+

Code: NCT02734537

Phase2, Recruiting

A Study on the Safety and Immune Response of a Urinary Tract Infection (UTI) Vaccine in Adults 18-64 Years of Age and Clinical Efficacy in Females 18-64 Years of Age

for
Urinary Tract Infections
Location: Seattle WA, Wenatchee WA, Lenexa KS, Weatherford TX,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18 - 64

Code: NCT06702449

Phase1, Phase2, Recruiting

A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injection in Participants With Advanced Solid Tumors (BEHOLD-1)

for
Solid Tumors, Neoplasms
Location: Seattle WA, Portland OR, Santa Rosa CA,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT06431594

Phase1, Recruiting

A Study of Investigational RSV/hMPV Combination and Investigational hMPV Vaccines in Younger and Older Adults

for
Respiratory Syncytial Virus Infections+Metapneumovirus
Location: Seattle WA, Lenexa KS
Sponsor: GlaxoSmithKline

Sex: All

Age: 18 - 70+

Code: NCT07628049

Phase1, Phase2, Recruiting

A Study on the Safety and Immune Response of Investigational mRNA Seasonal Flu/COVID-19 Combination Vaccine in Adults

for
Influenza, Human+COVID-19
Location: Seattle WA, Fair Oaks CA, San Diego CA, Austin TX,
Sponsor: GlaxoSmithKline

Sex: All

Age: 65 - 70+

Code: NCT07464314

Phase1, Recruiting

A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)

for
HIV Infections
Location: Seattle WA, Bakersfield CA, West Hollywood CA,
Sponsor: ViiV Healthcare

Sex: All

Age: 18+

Code: NCT07202546

Phase2, Recruiting

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

for
Obesity With Diabetes, Overweight With Diabetes
Location: Seattle WA, Missoula MT, Pleasant View UT,
Sponsor: Kailera

Sex: All

Age: 18+

Code: NCT07284901

Phase3, Recruiting
New

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Crinecerfont in Participants With Classic Congenital Adrenal Hyperplasia (CAH) Who Are Less Than 4 Years Old

for
Congenital Adrenal Hyperplasia
Location: Seattle WA, San Francisco CA, Philadelphia PA,
Sponsor: Neurocrine Switzerland GmbH

Sex: All

Age: 0 - 3

Code: NCT07536269

Phase2, Recruiting
New

A Study of the Preliminary Efficacy of DARE-HPV to Treat High-risk Persistent Human Papillomavirus (hrHPV)

for
Human Papilloma Virus (HPV),
Location: Seattle WA, Layton UT, Phoenix AZ, Little Rock AR
Sponsor: Daré Bioscience, Inc.

Sex: Female

Age: 22 - 50

Code: NCT07601074

Phase2, Recruiting

A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)

for
Chronic Inflammatory Demyelinating Polyneuropathy
Location: Seattle WA, Portland OR, San Francisco CA,
Sponsor: Dianthus Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT06858579

Phase3, Recruiting

AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)

for
Relapsed/Refractory Multiple Myeloma
Location: Seattle WA, Edmonds WA, San Francisco CA,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT05850234

Phase1, Phase2, Recruiting

Role of CYP2B6, CYP3A4, and MDR1 in the Metabolic Clearance of Methadone

for
Substance-Related Disorders
Location: Seattle WA
Sponsor: University of Washington

Sex: All

Age: 18 - 40

Code: NCT00504413

Phase1, Recruiting